Full name
OŚRODEK DIAGNOSTYKI I LECZENIA NIEPŁODNOŚCI MEDART SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
uses securityreCAPTCHA
OŚRODEK DIAGNOSTYKI I LECZENIA NIEPŁODNOŚCI MEDART SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
UL. JANINY OMAŃKOWSKIEJ 51, 60-465 POZNAŃ
TAX ID9721078161
Rate company:
OŚRODEK DIAGNOSTYKI I LECZENIA NIEPŁODNOŚCI MEDART SPÓŁKA Z OGRANICZONĄ ODPOWIEDZIALNOŚCIĄ
TAX ID9721078161
KRS0000191597
Share capital424,000.00 zł
address
UL. JANINY OMAŃKOWSKIEJ 51, 60-465 POZNAŃ
Categories
Main category
Is this your company?Update company information to get new customers, get notified of new reviews, and more!
Register Data
NIP
9721078161
REGON
634538674
KRS
0000191597
Legal form
limited liability company
Register Address
UL. JANINY OMAŃKOWSKIEJ 51, 60-465 POZNAŃ
Date of registration in KRS
2004-02-17
Date of commencement of economic activity
2004-02-17
Act signature
PO.VIII NS-REJ.KRS/10511/19/262/ADE
Pkd codes
86.10.Z - Hospital activities
62.01.Z - Activities related to programming, IT consulting, and related activities
63.11.Z - Services related to computing infrastructure, data processing, website management (hosting), and other information services
72.19.Z - Scientific research and development activities
85.59.B - Courses and training for acquiring knowledge, skills, and professional qualifications in non-school forms
85.60.Z - Educational support activities
86.21.Z - General medical practice
86.90.C - Healthcare
86.90.D - Healthcare
86.90.E - Healthcare
Payer VAT status
Active
Vat list bank account(s)
PL34 1090 1854 0000 0001 0240 6886 
Financial data
Net sales [PLN]
Gross profit / loss [PLN]
Automatically generated based on financial statements from KRS Registry
| 2021 | 2022 | 2023 | ||
|---|---|---|---|---|
M PLN | M PLN | M PLN | % | |
Gross profit (loss)  | 0,2 | -0,3 | 0,1 | 130,2 |
EBITDA | 0 | -0,2 | -0,1 | 62,2 |
Short time liabilities | 0,2 | 0,1 | 0,1 | 99,1 |
Equity capital | 1,3 | 1 | 1,1 | 8,3 |
Operating profit (EBIT) | -0 | -0,3 | -0,2 | 39,6 |
Assets | 1,5 | 1,1 | 1,2 | 14,1 |
Net profit (loss) | 0,2 | -0,3 | 0,1 | 130,2 |
Cash | 0,8 | 0,3 | 0,1 | -69,8 |
Net income from sale | 1,5 | 1,4 | 1,5 | 8,2 |
Liabilities and provisions for liabilities | 0,2 | 0,1 | 0,1 | 99,1 |
Working assets | 1,1 | 0,6 | 0,4 | -25 |
Depreciation | 0,1 | 0,1 | 0,1 | 39,5 |
% | % | % | p.p. | |
Profitability of capital | 16,4 | -27,5 | 7,7 | 35,2 |
Equity capital to total assets | 89,1 | 93,7 | 88,9 | -4,8 |
Gross profit margin | 14,3 | -20,4 | 5,7 | 26,1 |
EBITDA Margin | 1,5 | -15,9 | -5,6 | 10,3 |
Days | Days | Days | Days | |
Short term commitment turnover cycle | 38 | 18 | 34 | 16 |
Current financial liquidity indicator | -32,8 | |||
Net dept to EBITDA | 10,7 |
Financial statements
01-01-2023 - 31-12-2023
Annual financial report
Download xml01-01-2023 - 31-12-2023
Annual financial report
Download pdf01-01-2023 - 31-12-2023
Resolution on profit distribution or loss coverage
Download pdf01-01-2023 - 31-12-2023
Resolution or decision approving the annual financial statements
Download pdf01-01-2023 - 31-12-2023
Activity report
Download pdfShow more (2)
uses security reCAPTCHA
Opinions
Opinie dotyczące usług, produktów oraz działalności firmy nie są weryfikowane
0/ 5.0
How do you rate this company?
Your opinion matters to us.